
    
      The purpose of this registry is to expand upon existing data sets, to identify patient
      characteristics and indicators related to complications and clinical benefits for patients
      with symptomatic severe calcific degenerative aortic stenosis that are undergoing transaortic
      transcatheter procedure with the commercially available Edwards SAPIEN XT Transcatheter Heart
      Valve with the Ascendra+ System.
    
  